Guess what: one more reason to hate mosquitoes.
Sneaky, sneaky plasmodium.
A drug developed in the 1980s to fight parasites can make human blood toxic to mosquitoes when taken in a high dose.
Not one day too soon!
This looks like a better alternative to wiping out mosquitoes at the population level.
Hundreds of thousands of infants will be vaccinated against the mosquito-carried parasite.
A mosquito with a gene that blocks the malaria parasite has been created in the laboratory, a new research reports.
A lifelong dream may have come true. Half a million deaths every year could be averted thanks to this vaccine.
Believe it or not, there’s actual scientific proof backing this advice.
Chemists at the Ohio State University developed a paper strip technology that might save countless lives in rural Africa, and elsewhere where patients have poor access to medical services.
Scientists have in the past toyed with the idea of using a disease to fight cancer. Now, after identifying a malaria protein that binds to cancer cells and kills 95% of tumor types, human trials are expected to start within four years. I doesn’t seem like it’s happening fast, but it is, in medical terms. Clinical trials take a lot of
Researchers stumbled upon a new tool to fight cancer in a rather unexpected place; while searching for a vaccine against malaria in pregnant women, a team of Danish scientists found that, simply put, armed malaria proteins are remarkably good at killing cancer cells. They hope to have a working prototype ready for human trials within four years’ time. Their discovery has been published in the scientific journal Cancer Cell.
This year’s Nobel Prize in Physiology or Medicine is split into three parts, being divided between William C. Campbell and Satoshi Ōmura — who jointly share a half “for their discoveries concerning a novel therapy against infections caused by roundworm parasites” — and Youyou Tu “for her discoveries concerning a novel therapy against Malaria.”
The ability to keep malaria under control is crucial – the disease is highly contagious and the potential health hazards are immense. Efforts have been somewhat successful, with fatalities dropping from over 1 million in 2000 to 584,000 in 2014. But the protozoans that are causing the disease are starting to become immune to the drugs we are using, and that’s a huge problem.
Malaria is one of the most common and dangerous diseases in the world, with the World Health Organization estimating over 200 million cases every year. There are several ways to try to treat malaria, but the results are debatable and often times not as effective as desired. Now, a team has demonstrated a new compound which effectively destroys malaria in
Reporting in PLOS Medicine, researchers found that for every 1000 children who received the vaccine, 800 malaria cases can be prevented. While this is not yet sufficient to eradicate the disease, it is the closest scientists have gotten to a malaria vaccine. Malaria affects millions of people every year throughout the world, claiming just under 1 million lives in 2013
According to latest estimates by the World Health Organisation, over 3.4 billion people are at risk from contracting malaria and an estimated 627,000 people die each year from the disease. Thanks to the painstaking efforts of leading researchers in the field, however, much progress has been made in curbing down on malaria. Since 2000, increased prevention and control measures have
Aside from being really cool and enabling wicked video game graphics, 3D imaging is also extremely useful in research, entering the labs as one of the most powerful tools in the 21st century. Using an imaging technique known as high-speed holographic microscopy, Laurence Wilson, a fellow at Harvard’s Rowland Institute, created detailed 3D images of malaria sperm – the cells
It’s actually happening Good news – encouraging results from the longest and largest trial of a malaria vaccine could see the world’s first anti-malaria jab approved by 2015; malaria is one of the most dangerous diseases in the world, affecting over 220 million people every year (some say 300 million). The vaccine could be used for the first time in
Some 300 million cases of malaria are reported each year in Africa, the continent where the disease is still running rampant. For decades, scientists have been investing immense amounts of energy battling the disease, trying to come up with effective treatments. The recent step forward in the war against malaria comes from Maryland-based biotech Sanaria, which reportedly has developed an anti-malaria